In the 2 years since the COVID‐19 pandemic was officially declared, science has made
considerable strides in understanding the disease's pathophysiology, pharmacological …

Simple Summary Metabolic disorders (MD) are a challenge to healthcare systems; the
emergence of the modern socio-economic system has led to a profound change in lifestyles …

The SARS-CoV-19 pandemic overwhelmed multiple healthcare systems across the world.
Patients with underlying medical conditions such as obesity or diabetes were particularly …

Background We aimed to estimate the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) seroprevalence and describe its determinants and associated symptoms …

Background and Aim Few studies assessed the associations of overweight and obesity with
severe outcomes of coronavirus disease 2019 (COVID-19) among elderly patients. This …

The aim of this study was to provide additional data on mortality from COVID-19 with
particular attention to the factors associated with the positivity of patients admitted to the …

Results: Of 4,559 patients with COVID-19, 2,090 (45.8%) had type 2 diabetes. Patients with
COVID-19 with diabetes were older, more likely to receive mechanical ventilation, had …

Aims The objective was to compare anxiety, depression, and quality of life (QoL) in
individuals living with type 1 (T1D) and type 2 (T2D) diabetes with matched controls during …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) is a positive-sense-single
stranded RNA virus and the cause of the coronavirus disease 2019 (COVID-19). The World …

Background: Diabetes is a common comorbidity and risk factor of mortality in COVID-19 in
India but data on characteristics of diabetic COVID-19 is scarce. Objectives: We aimed to …